New Drugs & OTCs

05/18/2011 - 11:13am

Arizona Sunwash has announced the launch of Solise, which it is positioning as the world's first body wash and hand wash that combines cleansing with long-lasting UVA/UVB SPF 15 sunscreen.

05/17/2011 - 11:08am

Perrigo receives final approval for generic Zantac 150

Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

05/16/2011 - 11:03am

Mylan's generic Xibrom ophthalmic solution enters market

Mylan has launched a generic drug for treating post-operative inflammation in patients who have undergone cataract extraction, the company said Monday.

05/16/2011 - 10:16am

Generic, authorized generic of Amrix launched

Drug maker Mylan has launched a generic treatment for muscle spasms, the company said Friday.

05/16/2011 - 8:53am

Victrelis approved by FDA as chronic hepatitis C treatment

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

05/13/2011 - 2:55pm

Thinksport Livestrong sunscreen hits retail

In honor of Skin Cancer Awareness Month, Thinksport and Livestrong have announced that Thinksport Livestrong sunscreen now is available online and in stores just in time for summer.

05/13/2011 - 10:35am

PhRMA: More than 850 medicines in development for diseases that disproportionately affect women

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

05/13/2011 - 10:14am

Mylan launches generic Risperdal M-Tab

Generic drug maker Mylan has launched a version of a drug used to treat schizophrenia, the company said Friday.

05/11/2011 - 11:37am

Genentech seeks regulatory approval for vemurafenib

Genentech is seeking approval for a new drug to treat skin cancer, the company said Wednesday.

05/10/2011 - 11:53am

Report: Number of drug approvals by FDA may increase

The Food and Drug Administration expects to approve an increasing number of drugs, according to published reports.